A note on operating characteristics of the (S-1, S) inventory system with partial backorders and constant resupply timesSMEITINK, E.Management science. 1990, Vol 36, Num 11, pp 1413-1414, issn 0025-1909Article

Particle diffusion in a spheromakMEYERHOFER, D. D; LEVINTON, F. M; YAMADA, M et al.Physical review letters. 1988, Vol 60, Num 10, pp 933-936, issn 0031-9007Article

A note on the departure process in an (S-1, S) inventory systemPARK, K. S; AHN, B. H.International journal of systems science. 1984, Vol 15, Num 10, pp 1107-1109, issn 0020-7721Article

On the (S-1, S) inventory model under compound Poisson demands and i.i.d. unit resupply timesCHEUNG, K. L.Naval research logistics. 1996, Vol 43, Num 4, pp 563-572, issn 0894-069XArticle

Experimental study of a transformer-driven spheromak plasmaYOUNG, P. E; WYSOCKI, F. J; YAMADA, M et al.Physics of fluids. B, Plasma physics. 1991, Vol 3, Num 9, pp 2591-2600, issn 0899-8221Article

(S-1,S) policies for perishable inventorySCHMIDT, C. P; NAHMIAS, S.Management science. 1985, Vol 31, Num 6, pp 719-728, issn 0025-1909Article

(S-1, S) SPARE PART INVENTORY POLICY FOR FLEET MAINTENANCEPARK KS.1981; IEEE TRANS. RELIAB.; ISSN 0018-9529; USA; DA. 1981; VOL. 30; NO 5; PP. 481-483; BIBL. 5 REF.Article

WAITING TIME IN AN (S-1, S) INVENTORY SYSTEM. CONSTANT SERVICE TIME CASE.SHERBROOKE CC.1975; OPER. RES.; U.S.A.; DA. 1975; VOL. 23; NO 4; PP. 819-820; BIBL. 3 REF.Article

Denaturation of tilapia myosin fragments by hiqh Hydrostatic pressureKO, W.-C; HWANG, J.-S; JAO, C.-L et al.Journal of food science. 2004, Vol 69, Num 8, pp C604-C607, issn 0022-1147Article

THE (S-1, S) INVENTORY MODEL UNDER TIME LIMIT ON BACKORDERS.CHANDRASEKHAR DAS.1977; OPER. RES.; U.S.A.; DA. 1977; VOL. 25; NO 5; PP. 835-850; BIBL. 8 REF.Article

A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancerHEE MAN KIM; KYONG JOO LEE; JIHYE CHA et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 861-865, issn 0344-5704, 5 p.Article

Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancerKOSAKA, Takashi; AKIYAMA, Hirotoshi; MAKINO, Hirochika et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 2, pp 281-285, issn 0344-5704, 5 p.Article

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)YOSHIDA, M; ISHIGURO, M; MOCHIZUKI, H et al.Annals of oncology. 2014, Vol 25, Num 9, pp 1743-1749, issn 0923-7534, 7 p.Article

A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancerTAKAHARA, Naminatsu; ISAYAMA, Hiroyuki; SASAHIRA, Naoki et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 5, pp 985-990, issn 0344-5704, 6 p.Article

Efficacy and safety analysis according to histology for S-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: updated results of the West Japan Oncology Group LETS studyYOSHIOKA, H; OKAMOTO, I; KUDOH, S et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1326-1331, issn 0923-7534, 6 p.Article

Phase 2 Study of S-1 and Carboplatin Plus Bevacizumab Followed by Maintenance S-1 and Bevacizumab for Chemotherapy-Naive Patients With Advanced Nonsquamous Non―Small Cell Lung CancerURATA, Yoshiko; OKAMOTO, Isamu; TANAKA, Kaoru et al.Cancer. 2013, Vol 119, Num 12, pp 2275-2281, issn 0008-543X, 7 p.Article

Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lungKIYOTA, Hidemi; OKAMOTO, Isamu; AZUMA, Koichi et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 4, pp 859-865, issn 0344-5704, 7 p.Article

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancerKAIRA, Kyoichi; TOMIZAWA, Yoshio; SATO, Koji et al.Lung cancer. 2013, Vol 82, Num 1, pp 103-108, issn 0169-5002, 6 p.Article

Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1ZHAI, Jing-Ming; YIN, Xiao-Yu; LAI, Ying-Rong et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 5, pp 1255-1264, issn 0344-5704, 10 p.Article

Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancerKAIRA, Kyoichi; TOMIZAWA, Yoshio; HISADA, Takeshi et al.Lung cancer. 2013, Vol 82, Num 3, pp 449-454, issn 0169-5002, 6 p.Article

A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancerKAWAGUCHI, Tomoya; TAKADA, Minoru; SAITO, Ryusei et al.European journal of cancer (1990). 2012, Vol 48, Num 5, pp 672-677, issn 0959-8049, 6 p.Article

C-reactive Protein is a Potential Prognostic Factor for Metastatic Gastric CancerSHIMURA, Takaya; KITAGAWA, Mika; YAMADA, Tomonori et al.Anticancer research. 2012, Vol 32, Num 2, pp 491-496, issn 0250-7005, 6 p.Article

Comparison of Vinorelbine plus Cisplatin and S-1 plus Cisplatin in Concurrent Chemoradiotherapeutic Regimens for Unresectable Stage III Non-small Cell Lung CancerSHUKUYA, Takehito; TAKAHASHI, Toshiaki; NAITO, Tateaki et al.Anticancer research. 2012, Vol 32, Num 2, pp 675-680, issn 0250-7005, 6 p.Article

Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancerHASEGAWA, Masanori; MIYAJIMA, Akira; KOSAKA, Takeo et al.International journal of cancer (Print). 2012, Vol 130, Num 2, pp 431-442, issn 0020-7136, 12 p.Article

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancerKANAI, Masashi; YOSHIMURA, Kenichi; TAURA, Kojiro et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1429-1434, issn 0344-5704, 6 p.Article